The Study
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis
This study is like a science experiment in mice and cells. It shows that a drug called liraglutide is linked to less joint swelling, pain behaviors, and cartilage damage in mice with arthritis. But it doesn’t prove it will work the same way in people.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
A drug called liraglutide, used for diabetes, was tested in mice with sore joints. It helped reduce pain and swelling, and protected cartilage by calming down angry cells in the joint.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 512 / 100
Quality score
Detailed descriptions of individual patients or small groups. Valuable for identifying new conditions or side effects, but cannot establish generalizable conclusions.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This could mean liraglutide might help people with osteoarthritis, but it hasn't been tested in humans yet.
- 2One small shot of liraglutide (11 µg) reduced pain in 4 days.
- 3In cells, very tiny amounts (38–58 nM) reduced swelling chemicals and cartilage-damaging enzymes.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Scientific Reports
Year
2022
Authors
C. Meurot, C. Martin, L. Sudre, J. Breton, C. Bougault, R. Rattenbach, K. Bismuth, C. Jacques, F. Berenbaum
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.